MyriBase® Gel

Potential Savings In NHSE of £1.0 million through choosing MyriBase® Gel instead of Doublebase® Gel

MyriBase® Gel is a low cost Doublebase® Gel copy in a 500ml Pump2

MyriBase® Gel is a protective hydrating emollient for the treatment of dry skin conditions. Containing a higher oil content than an emollient cream, is light to the touch and non-greasy with the ease of absorption of a gel. It encourages rehydration and softening of dry skin by restoring the oils that provide the natural occlusive barrier within the epidermis, thus reducing drying as a result of the evaporation of water diffusing from the underlying layers. It contains isopropyl myristate 15% and liquid paraffin 15% and is free of fragrances and colourings. May be used as an adjunct to other topical treatments

calculation

How much could I save?

ICB Saving

£

£

£

CCG Saving

£

£

£

We do not have data available for your selected country to compare against.

Please call us on +44 (0)345 241 4330 or email info@penlanhealth.com for pricing

Saving vs. E45® Cream

The above calculator is solely to be used to articulate differences in acquisition costs. Source NHS Open Prescribing – PCA annual data Financial Year 2022 / 2023. E45® price rise from April 2023 included in the calculation.

Saving vs. Doublebase® Gel

The above calculator is solely to be used to articulate differences in acquisition costs. Source NHS Open Prescribing – PCA annual data Financial Year 2022 / 2023.

Saving vs. Aveeno® Cream, Zeroveen® Cream and AproDerm® Colloidal Oat Cream

The above calculator is solely to be used to articulate differences in acquisition costs. Source NHS Open Prescribing – PCA annual data Financial Year 2022 / 2023.

Saving vs. Cetraben® Cream

The above calculator is solely to be used to articulate differences in acquisition costs. Source NHS Open Prescribing – PCA annual data Financial Year 2022 / 2023.

Saving vs. HyloTear® and HyloForte®

The above calculator is solely to be used to articulate differences in acquisition costs. Source NHS Open Prescribing – PCA annual data Financial Year 2022 / 2023.

Saving vs. Glucogel®

The above calculator is solely to be used to articulate differences in acquisition costs. Source NHS Open Prescribing – PCA annual data Financial Year 2022 / 2023.

Product Documents

Product Description

MyriBase® Gel 500ml Pump at only £4.66 offers a 20% cost saving against the originator Doublebase® Gel 500g Pump at £5.83.2

Available since 2015 with continued supply.

MyriBase® Gel 500ml Pump at only £4.66 costs 20% less than Doublebase® Gel 500g Pump at £5.83, representing a potential saving of £1.0 million across NHSE in 2022 / 2023.1

15% Isopropyl Gels Isopropyl Myristate 15% Light Liquid Paraffin 15% 500g / 500ml Pump 500g Bottle
Doublebase® Gel Yes Yes Yes
MyriBase® Gel Yes Yes Yes
Epimax® Isomol Gel Yes Yes Yes
Zerodouble® Gel Yes Yes Yes
AproDerm® Gel Yes Yes Yes

INDICATIONS

For use as regular first-line treatment and prophylaxis of dry or chapped skin conditions that may also be pruritic or inflamed.

PREPARATIONS AVAILABLE

Gel

SIZES AVAILABLE

100g (tube); 500ml (pump)

 

General Emollient Advice

The Primary Care Dermatolgy Society (PCDS) state in their clinical guidance:

Emollients are the mainstay of therapy and without them it is not possible to manage eczema effectively. Good evidence shows that the more emollients are used, the less topical steroids are needed. Compliance is essential and so always review patients to check they are happy with what has been prescribed – it may be necessary to try a range of emollients before the patient settles on the best combination.

  • Moisturisers
    • Most patients prefer creams and gels. The most important factor is to find one that the patient likes and is happy to use
    • Ointments tend to be less well tolerated by patients, but they are less likely to cause contact allergic dermatitis as they do not contain preservatives (this is for both emollients and topical steroids)
    • Encourage appropriate usage by prescribing generous amounts e.g. 500 grams of moisturisers to use regularly (often QDS)
    • As with other topical treatments, moisturisers should be gently rubbed into the skin until they are no longer visible. They should be applied downward in the direction of the hairs to lessen the risk of folliculitis
    • Warn that they may sting for the first couple of days before soothing the skin
    • Ointments come in tubs and so can easily become cross infected with bacteria from the skin – patients must not place hands into tubs but instead use a utensil to scoop out the ointment
    • Order of application – if topical steroids are also being used, moisturisers can be applied first and allowed to dry for 15-20 minutes before applying the topical steroid

 https://www.pcds.org.uk/clinical-guidance/atopic-eczema

Emollients tend to have a short duration of action and will be required to be applied regularly or when needed.

MyriBase Gel is best applied when the skin is moist and should ideally be applied to the skin at least three or four times a day or as often as recommended by a healthcare professional to keep the skin well moisturised and in good condition. In particular, it is a good idea to regularly apply to the hands because they are exposed to the elements more than any other part of the body.

MyriBase Gel should be applied liberally to the affected area then smoothed into the skin along the line of hair growth, rather than rubbing it in.

Patients may also want to use MyriBase Gel after washing their hands, having a bath or taking a shower. Advise patents that when bathing they should use warm not hot water and to avoid staying in the bath too long as this can make dry skin conditions worse.

References
1 NHSE OpenData Financial year 2022
2 NHSBSA January 2023

TRADEMARKS
Doublebase® is a Trademark of Dermal Limited
Epimax® is a Trademark of Aspire Pharma Limited
Zerodouble® is a Trademark of Thornton & Ross Limited
AproDerm® is a Trademark of Fontus Health Limited
MyriBase® Gel is distributed in the United Kingdom by Galen Pharma
MyriBase® is a Registered trademark of Penlan Healthcare Limited
Penlan Healthcare Limited is the Registered Manufacturer of MyriBase® Gel

You may also like…

Title

Go to Top